Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Aug 19:59:27651.
doi: 10.3402/fnr.v59.27651. eCollection 2015.

Effect of a high intake of cheese on cholesterol and metabolic syndrome: results of a randomized trial

Rita Nilsen  1 , Arne Torbjørn Høstmark  2 , Anna Haug  3 , Siv Skeie  4
Affiliations

Effect of a high intake of cheese on cholesterol and metabolic syndrome: results of a randomized trial

Rita Nilsen et al. Food Nutr Res. .

Abstract

Background: Cheese is generally rich in saturated fat, which is associated with increased risk for cardiovascular diseases. Nevertheless, recent reports suggest that cheese may be antiatherogenic.

Objective: The goal of this study was to assess whether intake of two types of Norwegian cheese, with widely varying fat and calcium content, might influence factors of the metabolic syndrome and serum cholesterol levels differently.

Design: A total of 153 participants were randomized to one of three groups: Gamalost(®), a traditional fat- and salt-free Norwegian cheese (50 g/day), Gouda-type cheese with 27% fat (80 g/day), and a control group with a limited cheese intake. Blood samples, anthropometric measurements, blood pressure, and questionnaires about lifestyle and diet were obtained at inclusion and end.

Results: At baseline, there were no differences between the groups in relevant baseline characteristics, mean age 43, 52.3% female. After 8 weeks' intervention, there were no changes in any of the metabolic syndrome factors between the intervention groups compared with the control group. There were no increases in total- or LDL cholesterol in the cheese groups compared with the control. Stratified analysis showed that those in the Gouda group with metabolic syndrome at baseline had significant reductions in total cholesterol at the end of the trial compared with control (-0.70 mmol/L, p=0.013), and a significantly higher reduction in mean triglycerides. In the Gamalost group, those who had high total cholesterol at baseline had a significant reduction in total cholesterol compared with control (-0.40 mmol/L, p=0.035).

Conclusions: In conclusion, cholesterol levels did not increase after high intake of 27% fat Gouda-type cheese over 8 weeks' intervention, and stratified analysis showed that participants with metabolic syndrome had reduced cholesterol at the end of the trial.

Keywords: Gamalost; Gouda; cardiovascular diseases; dairy; intervention.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Flow chart of a single-blinded, randomized, controlled trial of Gamalost® and Norvegia® in 153 participants.
See this image and copyright information in PMC

References

    1. Alwan A. Global status report on noncommunicable diseases 2010. World Health Organization; 2011. Available from: http://www.who.int/nmh/publications/ncd_report_full_en.pdf [cited 3 January 2015].
    1. TINE. Norvegia original. 2014. Available from: http://www.tine.no/merkevarer/norvegia/produkter/norvegia [cited 22 October 2014].
    1. Karanja NM, Obarzanek E, Lin PH, McCollough ML, Phillips KM, Swain JF, et al. Descriptive characteristics of the dietary patterns used in the Dietary Approaches to Stop Hypertension Trial. DASH Collaborative Research Group. J Am Diet Assoc. 1999;99:S19–27. - PubMed
    1. Miller M, Stone NJ, Ballantyne C, Bittner V, Criqui MH, Ginsberg HN, et al. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2011;123:2292–333. - PubMed
    1. Høstmark AT, Tomten SE. The Oslo health study: cheese intake was negatively associated with the metabolic syndrome. J Am Coll Nutr. 2011;30:182–90. - PubMed